Pharmaceutical public policy / [edited by] Thomas R. Fulda, MA, Alan Lyles, ScD, MPH, RPh, Henry A. Rosenberg Professor of Government, Business and Noprofit Partnerships, University of Baltimore, Fellow, National Academy of Public Administration, Docent, University of Helsinki, Albert I. Wertheimer, PhD, MBA, Professor of Pharmaceutical Economics, Department of Pharmacy Practtice, Temple University School of Pharmacy, Philadelphia, PA.
2016
KF3885 .P53 2016 (Mapit)
Available at Stacks
Items
Details
Title
Pharmaceutical public policy / [edited by] Thomas R. Fulda, MA, Alan Lyles, ScD, MPH, RPh, Henry A. Rosenberg Professor of Government, Business and Noprofit Partnerships, University of Baltimore, Fellow, National Academy of Public Administration, Docent, University of Helsinki, Albert I. Wertheimer, PhD, MBA, Professor of Pharmaceutical Economics, Department of Pharmacy Practtice, Temple University School of Pharmacy, Philadelphia, PA.
Imprint
Boca Raton : CRC Press, Taylor & Francis Group, [2016]
Copyright
©2016.
Description
xv, 497 pages : illustrations ; 26 cm
Formatted Contents Note
Policy process / Alan Lyles
Federal legislative process / Valerie Heitshusen
Role of federal regulations and how they are developed / Curtis W. Copeland
Access, quality, and cost / Julie A. Schmittdiel and Marsha Raebel
Why is medication use less then appropriate? / Duane M. Kirking, David Nau, and Jill Augustine
Medication adherence and health policy / Meghan M. Kelly and Jon C. Schommer
Good governance and corruption in the pharmaceutical system / Jillian Clare Kohler - U.S. food and drug administration / Gregory Dolin
Risk minimization: a new regulatory challenge directive / Louis A. Morris and Eva Lydick
Drug shortages / Anna Gu, Dhamil Patel, and Rajesh Nayak
Drug reimportation into the United STates / Albert I. Wertheimer and Qian Ding
Competition between brand-name and generic drugs / Jianfei J. Guo and Christina M.L. Kelton
Structure and dynamics of the pharmaceutical industry / Earlene Lipowski
Health policy and economic issues in biotechnology and personalized medicine / Louis P. Garrison, Jr.
Pharmaceutical promotion in the United States / Alan Lyles
Health technology assessment / Laura T. Pizzi and Tony Amos
Pharmacoeconomics as a response to market failure: an international perspective / Ruth Lopert
Market for pharmaceuticals / David H. Kreling
Managed care pharmacy and pharmacy benefit management / Perry Cohen and Mary Claire Wohletz
Drug insurance design and management / Earle "Buddy" Lingle and William N. Yates
Electronic information technology: role in supporting drug use and policy / Gordon Schiff, Tewodros Ecuale, and Bill G. Felkey
Assessing medicare part D after 10 years / Jack Hoadley
Madicaid / Brian J. Isetts
The affordable care act: potential impacts on pharmaceutical markets / Steven H. Sheingold and Pierre L. Yong
Role of government as regulator, payer, and provider of care / W. Mike Heath and John Spain
Department of veterans affais pharmacy programs / Vaiyapuri Subramaniam and Michael A. Valentino
Public Health Service / Robert E. Pittman.
Federal legislative process / Valerie Heitshusen
Role of federal regulations and how they are developed / Curtis W. Copeland
Access, quality, and cost / Julie A. Schmittdiel and Marsha Raebel
Why is medication use less then appropriate? / Duane M. Kirking, David Nau, and Jill Augustine
Medication adherence and health policy / Meghan M. Kelly and Jon C. Schommer
Good governance and corruption in the pharmaceutical system / Jillian Clare Kohler - U.S. food and drug administration / Gregory Dolin
Risk minimization: a new regulatory challenge directive / Louis A. Morris and Eva Lydick
Drug shortages / Anna Gu, Dhamil Patel, and Rajesh Nayak
Drug reimportation into the United STates / Albert I. Wertheimer and Qian Ding
Competition between brand-name and generic drugs / Jianfei J. Guo and Christina M.L. Kelton
Structure and dynamics of the pharmaceutical industry / Earlene Lipowski
Health policy and economic issues in biotechnology and personalized medicine / Louis P. Garrison, Jr.
Pharmaceutical promotion in the United States / Alan Lyles
Health technology assessment / Laura T. Pizzi and Tony Amos
Pharmacoeconomics as a response to market failure: an international perspective / Ruth Lopert
Market for pharmaceuticals / David H. Kreling
Managed care pharmacy and pharmacy benefit management / Perry Cohen and Mary Claire Wohletz
Drug insurance design and management / Earle "Buddy" Lingle and William N. Yates
Electronic information technology: role in supporting drug use and policy / Gordon Schiff, Tewodros Ecuale, and Bill G. Felkey
Assessing medicare part D after 10 years / Jack Hoadley
Madicaid / Brian J. Isetts
The affordable care act: potential impacts on pharmaceutical markets / Steven H. Sheingold and Pierre L. Yong
Role of government as regulator, payer, and provider of care / W. Mike Heath and John Spain
Department of veterans affais pharmacy programs / Vaiyapuri Subramaniam and Michael A. Valentino
Public Health Service / Robert E. Pittman.
Summary
"Pharmaceutical Public Policy provides the understanding and framework required for effective organization, financing, and delivery of pharmaceutical products and services. It supplies an overview of the policy process as well as the roles of legislation and regulation in pharmaceutical policy.The book identifies the goals, objectives, and key policy issues of concern to stakeholders involved in the development of products, use of pharmaceuticals in healthcare, and administration of insurance programs by both the private and government sectors. Policy issues examined include the appropriateness of prescribing and patient adherence. Addressing questions of access, quality, and cost, the book considers the operation of the Affordable Care Act and Medicare Part D. It details the responsibilities of Federal providers of pharmaceutical care and private and public payers such as managed care organizations, pharmacy benefit managers, Medicare, and Medicaid. The book covers the policies and practices involved in promoting pharmaceutical products. It also considers pharmacoeconomics as a response to market failure. Finally, the book describes the market, the role of the manufacturer, drug shortages, and the responsibilities of the FDA."-- Publisher's description.
Note
"A Productivity Press book."
Bibliography, etc. Note
Includes bibliographical references and index.
Location
STA
Available in Other Form
Online version: Fulda, Thomas R. Pharmaceutical public policy. Boca Raton : CRC Press, 2016
Call Number
KF3885 .P53 2016
Language
English
ISBN
9781498748506 (hardback)
1498748503 (hardback)
9781498748513 (electronic book)
1498748511 (electronic book)
1498748503 (hardback)
9781498748513 (electronic book)
1498748511 (electronic book)
Record Appears in